A retrospective review of oral low-dose sirolimus (rapamycin) for the treatment of active uveitis

Overview of attention for article published in Journal of Ophthalmic Inflammation and Infection, December 2010

Altmetric Badge

About this Attention Score

Among the highest-scoring outputs from this source (#41 of 188)

Mentioned by

patent: 5 patents

Citations

dimensions_citation: 33 Dimensions

Readers on

mendeley: 14 Mendeley

Summary Patents Dimensions citations

So far, Dimensions has found 33 publications that cite this research output.

33

The most recent citing publications are shown below. View all 33 publications that cite this research output on Dimensions.

Rapamycin in Cerebral Cavernous Malformations: What Doses to Test in Mice and Humans

Article in ACS Pharmacology & Translational Science (April 2022)

Therapeutic Effect of Rapamycin-Loaded Small Extracellular Vesicles Derived from Mesenchymal Stem Cells on Experimental Autoimmune Uveitis

Article in Frontiers in Immunology (March 2022)

Current state and progress of rapamycin in the treatment of non-infectious uveitis

Article in Chinese Journal of Ocular Fundus Diseases (July 2021)